Czech and Slovak Diamond-Blackfan Anemia (DBA) Registry update: Clinical data and novel causative genetic lesions
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
31855845
DOI
10.1016/j.bcmd.2019.102380
PII: S1079-9796(19)30278-5
Knihovny.cz E-zdroje
- Klíčová slova
- Cancer, Diamond-Blackfan anemia (DBA), Mutations, Registry, Ribosomal proteins (RP),
- MeSH
- Diamondova-Blackfanova anemie komplikace epidemiologie genetika MeSH
- genetické asociační studie MeSH
- lidé MeSH
- mutace * MeSH
- nádory etiologie MeSH
- registrace MeSH
- ribozomální proteiny genetika MeSH
- rodina MeSH
- sekvenování exomu MeSH
- srovnávací genomová hybridizace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
- Slovenská republika MeSH
- Názvy látek
- ribosomal protein L11 MeSH Prohlížeč
- ribosomal protein L5, human MeSH Prohlížeč
- ribosomal protein S19 MeSH Prohlížeč
- ribozomální proteiny MeSH
Diamond-Blackfan anemia (DBA) is a rare congenital erythroid aplasia, underlied by haploinsufficient mutations in genes coding for ribosomal proteins (RP) in approximately 70% of cases. DBA is frequently associated with somatic malformations, endocrine dysfunction and with an increased predisposition to cancer. Here we present clinical and genetic characteristics of 62 patients from 52 families enrolled in the Czech and Slovak DBA Registry. Whole exome sequencing (WES) and array comparative genomic hybridization (aCGH) were employed to identify causative mutations in newly diagnosed patients and in cases with previously unrecognized molecular pathology. RP mutation detection rate was 81% (50/62 patients). This included 8 novel point mutations and 4 large deletions encompassing some of the RP genes. Malignant or predisposing condition developed in 8/62 patients (13%): myelodysplastic syndrome in 3 patients; breast cancer in 2 patients; colorectal cancer plus ocular tumor, diffuse large B-cell lymphoma and multiple myeloma each in one case. These patients exclusively harbored RPL5, RPL11 or RPS19 mutations. Array CGH is beneficial for detection of novel mutations in DBA due to its capacity to detect larger chromosomal aberrations. Despite the importance of genotype-phenotype correlation in DBA, phenotypic differences among family members harboring an identical mutation were observed.
Citace poskytuje Crossref.org
